COMPANY PRESENTATION

Conference Call FY 2024 Financial results

Mar. 14th , 2025

DISCLAIMER ²

Certain statements in this slide show, including those addressing the Company's beliefs, plans, objectives, estimates or expectations of possible future results or events, are forward-looking statements. Forward-looking statements involve known or unknown risks, including general economic and business conditions, and conditions in the industry we operate and may be affected should our assumptions turn out to be inaccurate. Consequently, no forward-looking statement can be guaranteed and actual future results, performance, or achievements may vary materially from those expressed or implied by such forward-looking statements. The Company undertakes no obligation about the contents nor to update the forward-looking statements to reflect events or circumstances that may arise after the date hereof.

	HIGHLIGHTS –	FY	2024
Euro '000
P&L	31/12/2023	%	31/12/2024	%	Var.%
	unaudited		unaudited
Revenues	576.011		565.846		-1,8%
EBIT	78.219	13,6%	78.309	13,8%	0,1%

Revenues	31/12/2023	%	31/12/2024	%	Var.%
Medical	392.434	68,1%	410.401	72,5%	4,6%
Industrial	183.577	31,9%	155.444	27,5%	-15,3%


Financials w/o IFRS5 accounting standard
P&L	31/12/2023	%	31/12/2024	%	Var.%
	unaudited		unaudited
Revenues	692.290		645.881		-6,7%
EBIT	72.736	10,5%	70.958	11,0%	-2,4%

Financials w/o IFRS5 accounting standard

Medical	392.434	68,1%	410.401	72,5%	4,6%
Industrial	183.577	31,9%	155.444	27,5% -15,3%


Financials w/o IFRS5 accounting standard
P&L	31/12/2023	%	31/12/2024	%	Var.%

Revenues	692.290		645.881		-6,7%
EBIT	72.736	10,5%	70.958	11,0%	-2,4%

	31/12/2023	%	31/12/2024
	unaudited		unaudited
NFP	54.586		120.364

emarket sdir storage
CERTIFIED

	INCOME STATEMENT –		FY 2024		4
Euro '000	31/12/2023	%	31/12/2024	%	Var. %
	unaudited		unaudited
Medical	392.434	68,1%	410.401	72,5%	4,6%
Industrial	183.577	31,9%	155.444	27,5%	-15,3%
Revenues	576.011	100,0%	565.846	100,0%	-1,8%
Gross margin	234.769	40,8%	245.637	43,4%	4,6%
Operating Expenses	50.091	8,7%	55.092	9,7%	10,0%
Staff espenses	92.494	16,1%	98.770	17,5%	6,8%
EBITDA	92.184	16,0%	91.775	16,2%	-0,4%
Depr., amort., accruals	13.965	2,4%	13.467	2,4%	-3,6%
EBIT	78.219	13,6%	78.309	13,8%	0,1%
Net financ.income(charges)	(449)	-0,1%	802	0,1%
Other income (expense) net	64	0,0%	4.993	0,9%	7642,1%
EBT	77.835	13,5%	84.104	14,9%	8,1%
Income taxes	(22.600)	-3,9%	(21.227)	-3,8%	-6,1%
Discontinued operations	(5.169)	-0,9%	(10.372)	-1,8%	100,7%
Minorities	(1.827)	-0,3%	(892)	-0,2%	-51,2%
NET INCOME	48.239	8,4%	51.613	9,1%	7,0%

	BALANCE SHEET – 2024
Euro '000	31/12/23 unaudited	31/12/24 unaudited	Var.%
Total non current assets	116.304	103.237	-11,2%
Net Working Capital	211.901	199.826	-5,7%
Other receivables/payables ST	(34.876)	(32.675)	-6,3%
Net financial position	59.877	110.559	84,6%
Long term liabilities	16.379	16.071	-1,9%
Net Equity	375.458	410.802	9,4%
Discontinued operation	38.630	45.926	18,9%
Net capital employed	315.581	300.243	-4,9%
Net Working Capital on sales	36,8%	35,3%
ROCE	24,8%	26,1%
(EBIT/Net capital employed)
Operating Capex	11.623	13.306